Having recently joined the team in 2022, Hannah Daniel is a reporter for Medtech Insight. She is interested in following Rx-to-OTC drug switches and investigating developments from clinical trials. She is the host for HBW’s Over the Counter Podcast U.S. and holds a bachelor’s degree in biology from Carnegie Mellon University.
Latest From Hannah Daniel
This exclusive infographic shows new review timelines the FDA announced for FY 2023 now that MDUFA V has been ratified.
Congress extended the Small Business Innovation Research and Small Business Technology Transfer programs, right before they were set to expire on 30 September.
The CDC’s $90m funding will be split among five laborites across the US over five years as a part of its pioneering Pathogen Genomics Centers of Excellence Network.
In a report published September 26, the FDA released the findings from its software pre-certification program which include the need for a new regulatory authority to supplement current regulations for medical devices.
The FDA granted 510(k) clearance to Applied Tissue Technologies for its non-foam negative pressure wound therapy system.
A CDC study found that fewer than half of children with sickle cell disease were getting screened for strokes, and fewer than 40% of children were taking recommended medications.